Latest News for: ilds

Edit

SSc-ILD Market on Track for Major Expansion by 2034, According to DelveInsight | MERCK, GlaxoSmithKline, ...

GetNews 10 Apr 2025
Topline results from the Phase III FIBRONEER-ILD trial (NCT05321082) showed that nerandomilast improved lung function in patients with progressive fibrosing interstitial lung diseases (PF-ILDs), excluding idiopathic pulmonary fibrosis (IPF).
Edit

phaware® Launches Special Series of Podcast Episodes Spotlighting the Future of PH-ILD Treatment and Innovation

Polk County Itemiser-Observer 02 Apr 2025
Liquidia, Pulmovant, and Gossamer Bio Partner with Nonprofit to Showcase Cutting-Edge Clinical Trials and Breakthrough Therapies ....
Edit

Endeavor BioMedicines Appoints Internationally Renowned ILD Expert Lisa Lancaster, M.D., as Chief Medical Officer

Business Wire 02 Apr 2025
A renowned pulmonologist and clinical researcher focused on interstitial lung disease (ILD), Dr.
  • 1

Article Search

tools
×
×
×
×